AbbVie was founded in 2013 as a global, research-based biopharmaceutical company committed to discovering, developing, and delivering innovative new medicines with distinct and compelling benefits for people. Today, AbbVie medicines help approximately 52 million people living in more than 175 countries, and AbbVie is making significant advancements with a robust pipeline of potential new medicines.
A Platform for Agile Development
AbbVie has invested in digital transformation since day one, building a best-in-class technology ecosystem that is ready to meet the demands of the business. But with multiple new product launches each year, digital transformation wasn’t a one-and-done project for AbbVie—it’s been an ongoing commitment.
